Question 1

What is the catalog number for Natalizumab (LC46-58)?

Accepted Answer

The catalog number for Natalizumab (LC46-58) is CRB1001726.

Question 2

What sizes are available for Natalizumab (LC46-58)?

Accepted Answer

Natalizumab (LC46-58) is available in the following size(s): 0.5 mg, 1 mg.

Question 3

How many pack sizes does Natalizumab (LC46-58) come in?

Accepted Answer

Natalizumab (LC46-58) is available in 2 different pack sizes.

Question 4

Is Natalizumab (LC46-58) in stock?

Accepted Answer

Natalizumab (LC46-58) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What happens if this product doesn’t perform as expected in my experiment?

Accepted Answer

Send us the catalogue number, product name, lot number, and a summary of your results. Our technical support team will investigate and, where needed, involve the manufacturer. This is covered under our guarantee provided the product was used before its expiry date and stored correctly.

Question 6

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Question 7

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Natalizumab (LC46-58)

Product Specifications

Synonyms

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

TMS1 (PYCARD) Human Gene Knockout Kit (CRISPR)

GAPDHS Rabbit Polyclonal Antibody

Tissue Total RNA, Bone

Human Gastrin Releasing Peptide (GRP) activation kit by CRISPRa

Tissue FFPE Sections, Prostate

Recombinant PPM1A Monoclonal Antibody